Filter
1327
Text search:
regimens
Featured
184
333
Language
Document type
701
265
199
60
39
28
20
7
3
3
1
Countries
78
52
52
32
31
29
27
26
26
23
20
17
15
15
14
13
13
12
11
10
10
8
8
8
8
8
8
8
8
7
6
6
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
469
228
69
68
29
18
14
Toolboxes
290
135
77
51
41
41
41
33
28
21
20
17
12
11
8
7
5
5
5
4
3
3
2
2
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Accessed November 2017
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Framework for implementation.
The END TB Strategy.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Good practice guide
Supporting community action on HIV, health and rights to end AIDS
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
Policy and Manual
Accessed November 2017
Accessed November 2017
A manual for programme managers.
БОРЬБА С ТУБЕРКУЛЕЗОМ В ТЮРЬМАХ
Руководство для руководителей программ
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
HIV/TB Research Meeting; March 3, 2013
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
A Guide For Multicentre Trials in High-Burden Countries
